Search
Menu
Home
HTB
2009
April
HTB
April 2009
Contents
Editorial
Volume 10 Number 3/4 Mar/Apr 2009
Conference reports
16th Conference on Retroviruses and Opportunistic Infections (CROI), 8-11 February 2009, Montreal
HIV infection in the brain: a long-term limitation of HAART?
When to start HAART – a key research question with the least available data
Major studies rule out any benefit of Interleukin-2 (IL-2): results from ESPRIT and SILCAAT
Higher rates of non-AIDS cancers in HIV positive people
Effect of breast feeding vs formula feeding on maternal health
PEPI-Malawi
Premature delivery and mother-to-child HIV transmission: a risk/benefit analysis among women receiving HAART
Risk factors for adverse pregnancy outcomes in Botswana
Higher risk of transmission with delayed control of maternal viral load despite viral loads of <500 copies/mL at delivery
Lopinavir/r containing regimen superior to nevirapine containing regimen in women previously exposed to single dose nevirapine
Covering the nevirapine tail
Effect of single dose nevirapine on subsequent nevirapine-containing HAART: long term outcomes
High rates of HIV acquisition in pregnancy and post partum in Francistown, Botswana
Children on HAART do extremely well at South African clinic
New boosting alternatives to ritonavir: GS-99350 and SPI-452
Interactions with raltegravir: with twice-daily atazanavir and standard dose lamotrigine
Effect of tenofovir on abacavir phosphorylation
Nevirapine: fluconazole and TB treatment
PI interactions: lopinavir/rifampicin, saquinavir, atazanavir/tenofovir in pregnancy
Identification of drug interactions in clinical practice
Effect of substance abuse on ART pharmacokinetics
PK and drug interactions
Effects of omeprazole on plasma levels of raltegravir
Interaction study of ketoconazole and ritonavir-boosted saquinavir
Tipranavir/ritonavir interactions with clarithromycin, fluconazole and rifabutin
Antiretroviral and statin drug-drug interactions
Guidelines
US Guidelines on prevention and treatment of opportunistic infections updated (2009)
BHIVA guidelines for TB/HIV coinfection (2009): online for comment
TB coinfection
WHO global TB control report highlights that 25% of TB-related deaths occur in HIV-positive people
Basic science and immunology
CD4 T-cell responses to commensal bacteria in the gut
Accelerated aging of the immune system in HIV infection
Immune recovery on antiretroviral therapy
Regulation gone awry? Elevated levels of regulatory T cells linked To disease progression
Viral resistance to a vaginal microbicide in macaques
Other news
Nations should reject UN drug policy
End of the Dr Rath affair in South Africa?
On the web
BHIVA/CHIVA Consensus Conference: Don’t Forget the Children
Hepatology: a clinical textbook
Human rights documentation and advocacy: a guide for organisations of people who use drugs
Online videos from Treatment Action Campaign, South Africa
PDFs
Volume 10 Number 3/4 March/April 2009 PDF
HTB RSS
Early access
Future PrEP and new results from PURPOSE 1 and 2: does HIV exposure explain incident cases?
21 November 2024
Glasgow HIV Congress 2024
10 November 2024
Unheard: The medical practice of silencing – by Dr Rageshri Dhairyawan
9 November 2024
Bipolar disorder in people living with HIV
1 November 2024
All early access reports
Current issues
November 2024
October 2024
September 2024
Back issues
Special report
HTB news: i-Base changes during 2024
1 November 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate